239 related articles for article (PubMed ID: 11872630)
1. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.
Cortessis VK; Siegmund K; Xue S; Ross RK; Yu MC
Carcinogenesis; 2003 Oct; 24(10):1645-50. PubMed ID: 12896908
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
7. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
10. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
11. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
[TBL] [Abstract][Full Text] [Related]
12. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
Weng WC; Huang YH; Yang SF; Wang SS; Kuo WH; Hsueh CW; Huang CH; Chou YE
Tumour Biol; 2016 May; 37(5):6971-7. PubMed ID: 26662954
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
[TBL] [Abstract][Full Text] [Related]
16. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
17. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
18. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
Forones NM; de Lima JM; de Souza LG; da Silva ID
J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
[TBL] [Abstract][Full Text] [Related]
20. Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma.
Yu J; Habuchi T; Tsuchiya N; Nakamura E; Kakinuma H; Horikawa Y; Inoue T; Ogawa O; Kato T
J Urol; 2004 Dec; 172(6 Pt 1):2410-3. PubMed ID: 15538282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
